TP53 and breast cancer: The association between low TP53BP2 expression and poor survival in TP53-mutated breast cancer seems counterintuitive at first, because TP53BP2 binds TP53 to induce apoptosis, and this pro-apoptotic cooperation can be defective or absent when TP53 is mutated [24, 25].